貽恒 的照片 李

查看斯高帕斯 (Scopus) 概要

李 貽恒

Professor

  • 3248 引文
  • 29 h-指數
1993 …2020
如果您對這些純文本內容做了任何改變，很快就會看到。

個人檔案

學歷

  • 國立成功大學基礎醫學研究所博士

研究專長

  • 心臟血管急重症學
  • 超音波心圖學
  • 診斷治療性心導管術

指紋 查看啟用 Yi-Heng Li 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。

  • 42 類似的檔案
Taiwan Medicine & Life Sciences
Thrombomodulin Medicine & Life Sciences
Myocardial Infarction Medicine & Life Sciences
Hydroxymethylglutaryl-CoA Reductase Inhibitors Medicine & Life Sciences
Atrial Appendage Medicine & Life Sciences
Acute Coronary Syndrome Medicine & Life Sciences
Left Atrial Function Medicine & Life Sciences
Coronary Artery Disease Medicine & Life Sciences

網絡 國家層面的近期外部合作。點選圓點深入探索詳細資料。

研究計畫 2019 2020

利用基因轉殖小鼠研究凝血調節素在血管新生內膜及動脈硬化中的角色

Li, Y.

19-08-01 → 20-07-31

研究計畫: Research project

研究成果 1993 2019

1 引文 (Scopus)

2019 Taiwan Society of Lipids and Atherosclerosis expert consensus statement on statin intolerance

Chien, S. C., Chen, P-S., Huang, Y. H., Tang, S. C., Li, Y-H. & Yeh, H. I., 2019 十月 1, 於 : Journal of the Formosan Medical Association. 118, 10, p. 1385-1392 8 p.

研究成果: Review article

開啟存取
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Taiwan
Atherosclerosis
Lipids
Liver

Antithrombotic treatment for symptomatic peripheral artery disease

Li, Y. H., Yeh, H. I. & Hwang, J. J., 2019 一月 1, 於 : Acta Cardiologica Sinica. 35, 6, p. 557-562 6 p.

研究成果: Review article

Peripheral Arterial Disease
clopidogrel
Therapeutics
Population Characteristics
Aspirin

A performance guide for major risk factors control in patients with atherosclerotic cardiovascular disease in Taiwan

Li, Y-H., Chen, J. W., Lin, T. H., Wang, Y. C., Wu, C. C., Yeh, H. I., Huang, C. C., Chang, K. C., Wu, C. K., Chen, P-W., Huang, C-W., Chen, Z. C., Chang, W. T., Huang, W. C., Wang, C. Y., Lee, M. Y., Chao, A. C., Fu, W. R., Tsai, L. K., Tang, S. C. 及其他5, Chan, H. L., Yang, Y-C., Wu, Y. W., Hwang, J. J. & Lin, J. L., 2019 一月 1, 於 : Journal of the Formosan Medical Association.

研究成果: Review article

開啟存取
Taiwan
Cardiovascular Diseases
Cerebrovascular Disorders
Peripheral Arterial Disease
Hypercholesterolemia
2 引文 (Scopus)

Changing practice pattern of acute coronary syndromes in Taiwan from 2008 to 2015

Li, Y-H., Chiu, Y. W., Cheng, J. J., Hsieh, I. C., Lo, P. H., Lei, M. H., Ueng, K. C., Chiang, F. T., Sung, S. H., Kuo, J. Y., Chen, C. P., Lai, W. T., Lee, W. L. & Chen, J. H., 2019 一月 1, 於 : Acta Cardiologica Sinica. 35, 1, p. 1-10 10 p.

研究成果: Article

Acute Coronary Syndrome
Taiwan
Registries
Percutaneous Coronary Intervention
Drug-Eluting Stents
1 引文 (Scopus)

Duration of clopidogrel-based dual antiplatelet therapy and clinical outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention: A real-world observation in Taiwan from 2012 to 2015

Taiwan ACS STENT Registry Investigators, 2019 一月 1, 於 : Circulation Journal. 83, 6, p. 1317-1323 7 p.

研究成果: Article

開啟存取
clopidogrel
Percutaneous Coronary Intervention
Acute Coronary Syndrome
Taiwan
Observation

論文

The vascular endothelial cell protective effect of recombinant thrombomodulin is regulated by autophagy

作者: 國豪, 江., 2015 八月 11

監督員: Li, Y. (Supervisor)

學生論文: Master's Thesis